Price $14.81 |
Market Cap
775.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.13
|
P/S
0.71
|
Dividend %
-
|
|
P/CF
13.9
|
P/FCF
4.0
|
Op. Cash Flow
191.3K
|
FCF
3.7
|
|
Op. Margin
3.00%
|
Net Margin
-1.30%
|
ROE
-9.60%
|
ROI
7.50%
|
|
ROA
-0.80%
|
EPS Growth
-136.00%
|
Current Ratio
0.7
|
Debt/Equity
432.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $9.26 | - | - | 107.7M | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.62 | - | - | 38.6M | Strong Buy |
| Tivity Health Inc (TVTY) | $14.12 | - | - | 783.8M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $0.25 | - | - | 19.6M | Strong Buy |
| The Providence Service Corpora (PRSC) | $88.09 | - | - | 1.31B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
